Alternative statutory remedy and unexplained delay barred writ review of customs confiscation adjudication, leaving merits for appellate consideration...
Authorised courier due diligence protects against penalties where declared exports conceal prohibited goods despite proper documentation and customs p...
Customs-controlled container movement now extends to DP World facilities, subject to segregation, inspections, reconciliation, and EXIM cargo priority...
The HC held that the product manufactured under a valid drug licence is classifiable as a drug/medicine under Entry 19-A, Part II, Schedule II of the MPVAT Act, and not as a cosmetic/beauty product. The HC quashed the impugned orders of the Commercial Tax Appellate Board and the Commercial Tax Board that had reclassified the product under other Schedule entries, answered the legal questions in favour of the appellant, and directed that the appellant is not liable to pay interest under Section 18(1)(a) of the MPVAT Act. Both VAT appeals were allowed and the appeals disposed.
The HC held that the product manufactured under a valid drug licence is classifiable as a drug/medicine under Entry 19-A, Part II, Schedule II of the MPVAT Act, and not as a cosmetic/beauty product. The HC quashed the impugned orders of the Commercial Tax Appellate Board and the Commercial Tax Board that had reclassified the product under other Schedule entries, answered the legal questions in favour of the appellant, and directed that the appellant is not liable to pay interest under Section 18(1)(a) of the MPVAT Act. Both VAT appeals were allowed and the appeals disposed.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4828 
Join Channel 
